alanine has been researched along with Lymphocytopenia in 3 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with hematological malignancies (HMs) are at a higher risk of developing severe form and protracted course of COVID-19 disease." | 1.72 | Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies. ( Diószegi, Á; Farkas, K; Hevessy, Z; Illés, Á; Magyari, F; Nagy, B; Nagy, G; Páyer, E; Pinczés, LI; Sik, M; Simon, Z; Ujfalusi, S, 2022) |
| " The relevance of circadian dosing time was investigated for chronotherapeutic optimization of SDX-102." | 1.33 | Circadian pharmacology of L-alanosine (SDX-102) in mice. ( Carrière, J; Crépin, D; Elliott, G; Guettier, C; Kanekal, S; Lévi, F; Li, XM, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Magyari, F | 1 |
| Pinczés, LI | 1 |
| Páyer, E | 1 |
| Farkas, K | 1 |
| Ujfalusi, S | 1 |
| Diószegi, Á | 1 |
| Sik, M | 1 |
| Simon, Z | 1 |
| Nagy, G | 1 |
| Hevessy, Z | 1 |
| Nagy, B | 1 |
| Illés, Á | 1 |
| Furlan, A | 1 |
| Forner, G | 1 |
| Cipriani, L | 1 |
| Vian, E | 1 |
| Rigoli, R | 1 |
| Gherlinzoni, F | 1 |
| Scotton, P | 1 |
| Li, XM | 1 |
| Kanekal, S | 1 |
| Crépin, D | 1 |
| Guettier, C | 1 |
| Carrière, J | 1 |
| Elliott, G | 1 |
| Lévi, F | 1 |
3 other studies available for alanine and Lymphocytopenia
| Article | Year |
|---|---|
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies.
Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Hematolog | 2022 |
Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.
Topics: Adenosine Monophosphate; Alanine; B-Lymphocytes; Combined Modality Therapy; COVID-19; COVID-19 Drug | 2021 |
Circadian pharmacology of L-alanosine (SDX-102) in mice.
Topics: Alanine; Animals; Antineoplastic Agents; Body Weight; Bone Marrow; Chronotherapy; Darkness; Gene Exp | 2006 |